CUE
NASDAQ · Biotechnology
Cue Biopharma Inc
$0.32
+0.00 (+1.27%)
Open$0.31
Previous Close$0.32
Day High$0.33
Day Low$0.30
52W High$19.07
52W Low$10.79
Volume—
Avg Volume230.2K
Market Cap29.21M
P/E Ratio20.31
EPS$0.63
SectorBiotechnology
Analyst Ratings
Strong Buy
6 analysts
Price Target
+4,820.3% upside
Current
$0.32
$0.32
Target
$15.75
$15.75
$10.91
$15.75 avg
$18.65
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 17.29M | 17.52M | 19.24M |
| Net Income | -1,405,095 | -1,532,650 | -1,824,826 |
| Profit Margin | -8.1% | -8.8% | -9.5% |
| EBITDA | -1,931,193 | -1,913,244 | -2,419,019 |
| Free Cash Flow | -1,435,133 | -1,533,941 | -1,392,757 |
| Rev Growth | -1.5% | +0.6% | +3.6% |
| Debt/Equity | 1.21 | 1.52 | 1.36 |
Dividend
Dividend Yield1.62%
Annual Dividend$0.21
Payout Ratio33.0%
Frequencysemi-annual
Ex-DividendApr 4, 2026
Pay DateApr 21, 2026
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $223.43 | +2.01% | 165.4 | 394.89B |
| AMGN | Amgen Inc | $384.32 | +4.49% | 26.8 | 206.95B |
| GILD | Gilead Sciences Inc | $152.50 | +2.10% | 23.3 | 189.20B |
| VRTX | Vertex Pharmaceuticals Inc | $477.92 | +4.17% | 33.7 | 123.82B |
| REGN | Regeneron Pharmaceuticals | $785.51 | +2.46% | 18.4 | 83.03B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.16 | -0.93% | 995.2 | 43.35B |